Value of Screening Trials in Neuromodulation Therapies

Monday, September 19th
1:00pm4:30pm EDT

About the Session

Neuromodulation Special Interest Group Symposium: PM Sessions

Register Now >

Learning Objectives:

  1. Learn the objective of screening trials.
  2. Explore the available information on the diagnostic value of screening trials.
  3. Learn the patient benefit of screening trials as well as the potential economic impact.



13:00 –  Symposia Begins and Opening Remarks

13:30-14:15 –  A Review of the Guidelines and Clinical Conduct of Trial in Neurmodulation Therapies with Dr John Markman Rochester (USA)

14:15-14:30 – Q&A

14:30-15:15 – A Systematic Review of the Evidence on Conduct of Trials in Spinal Cord Stimulation with Dr Harsha Shantana (Canada)

15:15-15:30 – Q&A

15:30-16:15 – Patient Benefit and Economic Impact of conduct of screening trials in Spinal Stimulation and Intrathecal Drug Delivery with Prof Sam Eldabe Middlesbrough UK

16:15-16:30 – Q&A

16:30 – Closing Remarks